{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:08:01Z","timestamp":1793012881327,"version":"4.5.0"},"reference-count":149,"publisher":"American Academy of Pediatrics (AAP)","issue":"Supplement_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:p>Changes in puberty timing have implications for the treatment of individual children, for the risk of later adult disease, and for chemical testing and risk assessment for the population. Children with early puberty are at a risk for accelerated skeletal maturation and short adult height, early sexual debut, potential sexual abuse, and psychosocial difficulties. Altered puberty timing is also of concern for the development of reproductive tract cancers later in life. For example, an early age of menarche is a risk factor for breast cancer. A low age at male puberty is associated with an increased risk for testicular cancer according to several, but not all, epidemiologic studies. Girls and, possibly, boys who exhibit premature adrenarche are at a higher risk for developing features of metabolic syndrome, including obesity, type 2 diabetes, and cardiovascular disease later in adulthood. Altered timing of puberty also has implications for behavioral disorders. For example, an early maturation is associated with a greater incidence of conduct and behavior disorders during adolescence. Finally, altered puberty timing is considered an adverse effect in reproductive toxicity risk assessment for chemicals. Recent US legislation has mandated improved chemical testing approaches for protecting children's health and screening for endocrine-disrupting agents, which has led to changes in the US Environmental Protection Agency's risk assessment and toxicity testing guidelines to include puberty-related assessments and to the validation of pubertal male and female rat assays for endocrine screening.<\/jats:p>","DOI":"10.1542\/peds.2007-1813g","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T18:55:35Z","timestamp":1201892135000},"page":"S218-S230","source":"Crossref","is-referenced-by-count":397,"title":["Public Health Implications of Altered Puberty Timing"],"prefix":"10.1542","volume":"121","author":[{"given":"Mari S.","family":"Golub","sequence":"first","affiliation":[{"name":"Department of Environmental Toxicology, University of California, Davis, California"},{"name":"California Environmental Protection Agency, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen W.","family":"Collman","sequence":"additional","affiliation":[{"name":"Division of Extramural Research and Training"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.D.","family":"Foster","sequence":"additional","affiliation":[{"name":"National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Kimmel","sequence":"additional","affiliation":[{"name":"National Center for Environmental Assessment, Office of Research and Development, US Environmental Protection Agency, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Rajpert-De Meyts","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward O.","family":"Reiter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baystate Children's Hospital, Springfield, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Sharpe","sequence":"additional","affiliation":[{"name":"Medical Research Council Human Reproductive Sciences Unit, University of Edinburgh, Edinburgh, Scotland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels E.","family":"Skakkebaek","sequence":"additional","affiliation":[{"name":"Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[{"name":"Departments of Physiology and Pediatrics, University of Turku, Turku, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,2,1]]},"reference":[{"key":"2021120820363328700_R1","doi-asserted-by":"crossref","unstructured":"Euling SY, Herman-Giddens ME, Lee PA, et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics.\u20082008;121;2(2 suppl):S172\u2013S191","DOI":"10.1542\/peds.2007-1813D"},{"key":"2021120820363328700_R2","doi-asserted-by":"crossref","unstructured":"Lee PA, Guo SS, Kulin HE. Age of puberty: data from the United States of America. APMIS.\u20082001;109(2):81\u201388","DOI":"10.1034\/j.1600-0463.2001.d01-107.x"},{"key":"2021120820363328700_R3","doi-asserted-by":"crossref","unstructured":"Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race. Pediatrics.\u20082001;108(2):347\u2013353","DOI":"10.1542\/peds.108.2.347"},{"key":"2021120820363328700_R4","doi-asserted-by":"crossref","unstructured":"Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics.\u20082002;110(5):903\u2013910","DOI":"10.1542\/peds.110.5.903"},{"key":"2021120820363328700_R5","doi-asserted-by":"crossref","unstructured":"Kaplowitz PB. The link between body fat and the timing of puberty. Pediatrics.\u20082008;121;2(suppl 3):S208\u2013S217","DOI":"10.1542\/peds.2007-1813F"},{"key":"2021120820363328700_R6","unstructured":"Grumbach MM, Styne DM. Puberty: ontogeny, neuroendocrinology, physiology and disorders. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia, PA: WB Saunders; 2003:1115\u20131286"},{"key":"2021120820363328700_R7","doi-asserted-by":"crossref","unstructured":"Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics.\u20081997;99(4):505\u2013512","DOI":"10.1542\/peds.99.4.505"},{"key":"2021120820363328700_R8","doi-asserted-by":"crossref","unstructured":"Reiter EO, Lee PA. Have the onset and tempo of puberty changed?Arch Pediatr Adolesc Med.\u20082001;155(9):988\u2013989","DOI":"10.1001\/archpedi.155.9.988"},{"key":"2021120820363328700_R9","doi-asserted-by":"crossref","unstructured":"Iba\u0301n\u0303ez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche: normal variant or forerunner of adult disease?Endocr Rev.\u20082000;21(6):671\u2013696","DOI":"10.1210\/edrv.21.6.0416"},{"key":"2021120820363328700_R10","doi-asserted-by":"crossref","unstructured":"Sopher AB, Thornton JC, Silfen ME, et al. Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls. J Clin Endocrinol Metab.\u20082001;86(11):5269\u20135272","DOI":"10.1210\/jcem.86.11.8045"},{"key":"2021120820363328700_R11","doi-asserted-by":"crossref","unstructured":"Kaplowitz PB, Oberfield SE; Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Pediatrics.\u20081999;104(4 pt 1):936\u2013941","DOI":"10.1542\/peds.104.4.936"},{"key":"2021120820363328700_R12","doi-asserted-by":"crossref","unstructured":"Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated girls. J Clin Endocrinol Metab.\u20081999;84(2):415\u2013423","DOI":"10.1210\/jc.84.2.415"},{"key":"2021120820363328700_R13","doi-asserted-by":"crossref","unstructured":"Palmert MR, Boepple PA. Variation in the timing of puberty: clinical spectrum and genetic investigation. J Clin Endocrinol Metab.\u20082001;86(6):2364\u20132368","DOI":"10.1210\/jcem.86.6.7603"},{"key":"2021120820363328700_R14","doi-asserted-by":"crossref","unstructured":"Grumbach MM. The neuroendocrinology of human puberty revisited. Horm Res.\u20082002;57(suppl 2):2\u201314","DOI":"10.1159\/000058094"},{"key":"2021120820363328700_R15","doi-asserted-by":"crossref","unstructured":"Paul D, Conte FA, Grumbach MM, Kaplan SL. Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than 5 years. J Clin Endocrinol Metab.\u20081995;80(2):546\u2013551","DOI":"10.1210\/jcem.80.2.7852518"},{"key":"2021120820363328700_R16","doi-asserted-by":"crossref","unstructured":"Kletter GB, Kelch RP. Effects of gonadotropin releasing-hormone analog therapy on adult stature in precocious puberty. J Clin Endocrinol Metab.\u20081994;79(2):331\u2013334","DOI":"10.1210\/jcem.79.2.8045943"},{"key":"2021120820363328700_R17","doi-asserted-by":"crossref","unstructured":"Iba\u0301n\u0303ez L, Potau N, Chacon P, Pascual C, Carrascova A. Hyperinsulinaemia, dyslipidaemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologia.\u20081998;41(9):1057\u20131063","DOI":"10.1007\/s001250051030"},{"key":"2021120820363328700_R18","doi-asserted-by":"crossref","unstructured":"Iba\u0301n\u0303ez L, Ong K, Potau N, Marcos MV, De Zegher F, Dunger D. Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche and hyperinsulinism sequence. J Clin Endocrinol Metab.\u20082001;86(12):5788\u20135793","DOI":"10.1210\/jcem.86.12.8093"},{"key":"2021120820363328700_R19","doi-asserted-by":"crossref","unstructured":"Silfen ME, Manibo AM, McMahon DJ, Levine LS, Murphy AR, Oberfield SE. Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche: the fasting glucose to insulin ratio may be a simple and useful measure. J Clin Endocrinol Metab.\u20082001;86(6):2863\u20132868","DOI":"10.1210\/jc.86.6.2863"},{"key":"2021120820363328700_R20","doi-asserted-by":"crossref","unstructured":"Teixeira RJ, Silva VC, Gazolla HM, Cunha SB, Guimaraes MM. The relationship between ovarian structure and serum insulin, insulin-like growth factor-1 (IGF-1) and its binding protein (IGFBP-1 and IGFBP-3) levels in premature pubarche. J Pediatr Endocrinol Metab.\u20082002;15(1):69\u201375","DOI":"10.1515\/JPEM.2002.15.1.69"},{"key":"2021120820363328700_R21","doi-asserted-by":"crossref","unstructured":"Dimartino-Nardi J. Premature adrenarche: findings in prepubertal African-American and Caribbean-Hispanic girls. Acta Paediatr Suppl.\u20081999;88(433):67\u201372","DOI":"10.1111\/j.1651-2227.1999.tb14406.x"},{"key":"2021120820363328700_R22","unstructured":"DiMartino-Nardi J. Pre- and postpubertal findings in premature adrenarche. J Pediatr Endocrinol Metab.\u20082000;13(suppl 5):1265\u20131269"},{"key":"2021120820363328700_R23","doi-asserted-by":"crossref","unstructured":"Apter D, Butzow T, Laughlin GA, Yen SS. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. J Clin Endocrinol Metab.\u20081995;80(10):2966\u20132973","DOI":"10.1210\/jcem.80.10.7559882"},{"key":"2021120820363328700_R24","doi-asserted-by":"crossref","unstructured":"Frontini MG, Srinivasan SR, Berenson GS. Longitudinal changes in risk variables underlying metabolic syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart study. Int J Obes Relat Metab Disord.\u20082003;27(11):1398\u20131404","DOI":"10.1038\/sj.ijo.0802422"},{"key":"2021120820363328700_R25","doi-asserted-by":"crossref","unstructured":"Denburg MR, Silfen ME, Manibo AM, et al. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J Clin Endocrinol Metab.\u20082002;87(12):5604\u20135609","DOI":"10.1210\/jc.2002-020896"},{"key":"2021120820363328700_R26","doi-asserted-by":"crossref","unstructured":"Potau N, Iba\u0301n\u0303ez L, Sanchez-Ufarte C, Rique S, de Zegher F. Pronounced adrenarche and precocious pubarche in boys. Horm Res.\u20081999;51(5):238\u2013241","DOI":"10.1159\/000023377"},{"key":"2021120820363328700_R27","doi-asserted-by":"crossref","unstructured":"Iba\u0301n\u0303ez L, Potau N, Francois I, De Zegher F. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab.\u20081998;83(10):3558\u20133562","DOI":"10.1210\/jcem.83.10.5205"},{"key":"2021120820363328700_R28","doi-asserted-by":"crossref","unstructured":"Iba\u0301n\u0303ez L, Potau N, De Zegher F. Endocrinology and metabolism after premature pubarche in girls. Acta Paediatr Suppl.\u20081999;88(433):73\u201377","DOI":"10.1111\/j.1651-2227.1999.tb14407.x"},{"key":"2021120820363328700_R29","doi-asserted-by":"crossref","unstructured":"Meas T, Chevenne D, Thibaud E, et al. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin Endocrinol (Oxf).\u20082002;57(1):101\u2013106","DOI":"10.1046\/j.1365-2265.2002.01579.x"},{"key":"2021120820363328700_R30","doi-asserted-by":"crossref","unstructured":"Shuttleworth F. The Physical and Mental Growth of Girls and Boys Age Six to Nineteen in Relation to Age at Maximum Growth. Vol IV, No. 3 (Serial No. 22). Washington, DC: National Research Council; 1939","DOI":"10.2307\/1165457"},{"key":"2021120820363328700_R31","unstructured":"Schambach H, Schneemann K, Mu\u0308ller E. Psychic and intellectual development in girls with precocious puberty. Endokrinologie.\u20081979;74(1):47\u201351"},{"key":"2021120820363328700_R32","doi-asserted-by":"crossref","unstructured":"Galatzer A, Beth-Halachmi N, Kauli R, Laron Z. Intellectual function of girls with precocious puberty. Pediatrics.\u20081984;74(2):246\u2013249","DOI":"10.1542\/peds.74.2.246"},{"key":"2021120820363328700_R33","doi-asserted-by":"crossref","unstructured":"Ehrhardt AA, Meyer-Bahlburg HF. Idiopathic precocious puberty in girls: long-term effects on adolescent behavior. Acta Endocrinol Suppl (Copenh).\u20081986;279:247\u2013253","DOI":"10.1530\/acta.0.112S247"},{"key":"2021120820363328700_R34","doi-asserted-by":"crossref","unstructured":"Ehrhardt AA, Meyer-Bahlburg HF. Psychosocial aspects of precocious puberty. Horm Res.\u20081994;41(suppl 2):30\u201335","DOI":"10.1159\/000183956"},{"key":"2021120820363328700_R35","doi-asserted-by":"crossref","unstructured":"Mul D, Versluis-den Bieman HJ, Slijper FM, Oostdijk W, Waelkens JJ, Drop SL. Psychological assessments before and after treatment of early puberty in adopted children. Acta Paediatr.\u20082001;90(9):965\u2013971","DOI":"10.1111\/j.1651-2227.2001.tb01349.x"},{"key":"2021120820363328700_R36","doi-asserted-by":"crossref","unstructured":"Rovet J. Cognitive and neuropsychological test performance of persons with abnormalities of adolescent development: a test of Waber's hypothesis. Child Dev.\u20081983;54(4):941\u2013950","DOI":"10.1111\/j.1467-8624.1983.tb00515.x"},{"key":"2021120820363328700_R37","doi-asserted-by":"crossref","unstructured":"Mazur T, Clopper RR. Pubertal disorders: psychology and clinical management. Endocrinol Metab Clin North Am.\u20081991;20(1):211\u2013230","DOI":"10.1016\/S0889-8529(18)30289-5"},{"key":"2021120820363328700_R38","unstructured":"Mouridsen SE, Larsen FW. Psychological aspects of precocious puberty: an overview. Acta Paedopsychiatr.\u20081992;55(1):45\u201349"},{"key":"2021120820363328700_R39","doi-asserted-by":"crossref","unstructured":"Officioso A, Salerno M, Lettiero T, Micillo M, Pisaturo L, Di Maio S. Adolescent girls with idiopathic central precocious puberty: typical character traits. J Pediatr Endocrinol Metab.\u20082000;13(suppl 1):835\u2013839","DOI":"10.1515\/JPEM.2000.13.S1.835"},{"key":"2021120820363328700_R40","doi-asserted-by":"crossref","unstructured":"Xhrouet-Heinrichs D, Lagrou K, Heinrichs C, et al. Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy. Acta Paediatr.\u20081997;86(8):808\u2013815","DOI":"10.1111\/j.1651-2227.1997.tb08602.x"},{"key":"2021120820363328700_R41","doi-asserted-by":"crossref","unstructured":"Baumann DA, Landolt MA, Wetterwald R, Dubuis JM, Sizonenko PC, Werder EA. Psychological evaluation of young women after medical treatment for central precocious puberty. Horm Res.\u20082001;56(1\u20132):45\u201350","DOI":"10.1159\/000048089"},{"key":"2021120820363328700_R42","doi-asserted-by":"crossref","unstructured":"Galdos PM, van Os JJ, Murray RM. Puberty and the onset of psychosis. Schizophr Res.\u20081993;10(1):7\u201314","DOI":"10.1016\/0920-9964(93)90071-P"},{"key":"2021120820363328700_R43","doi-asserted-by":"crossref","unstructured":"Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence. J Psychiatr Res.\u20081982;17(4):319\u2013334","DOI":"10.1016\/0022-3956(82)90038-3"},{"key":"2021120820363328700_R44","doi-asserted-by":"crossref","unstructured":"Feinberg I. Metabolic brain changes in adolescence: one aspect of a global reorganization. Ann Neurol.\u20081988;24(3):464\u2013465","DOI":"10.1002\/ana.410240323"},{"key":"2021120820363328700_R45","doi-asserted-by":"crossref","unstructured":"Keshavan M, Anderson S, Pettegrew J. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res.\u20081994;28(3):239\u2013265","DOI":"10.1016\/0022-3956(94)90009-4"},{"key":"2021120820363328700_R46","doi-asserted-by":"crossref","unstructured":"McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry.\u20082000;57(7):637\u2013648","DOI":"10.1001\/archpsyc.57.7.637"},{"key":"2021120820363328700_R47","doi-asserted-by":"crossref","unstructured":"Saugstad LF. Age at puberty and mental illness. Towards a neurodevelopmental aetiology of Kraepelin's endogenous psychoses. Br J Psychiatry.\u20081989;155:536\u2013544","DOI":"10.1192\/bjp.155.4.536"},{"key":"2021120820363328700_R48","doi-asserted-by":"crossref","unstructured":"Saugstad LF. Mental illness and cognition in relation to age at puberty: a hypothesis. Clin Genet.\u20081989;36(3):156\u2013167","DOI":"10.1111\/j.1399-0004.1989.tb03182.x"},{"key":"2021120820363328700_R49","doi-asserted-by":"crossref","unstructured":"Saugstad LF. The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia. Int J Psychophysiol.\u20081994;18(3):189\u2013203","DOI":"10.1016\/0167-8760(94)90005-1"},{"key":"2021120820363328700_R50","doi-asserted-by":"crossref","unstructured":"Saugstad LF. Manic depressive psychosis and schizophrenia are neurological disorders at the extremes of CNS maturation and nutritional disorders associated with a deficit in marine fat. Med Hypotheses.\u20082001;57(6):679\u2013692","DOI":"10.1054\/mehy.2001.1391"},{"key":"2021120820363328700_R51","doi-asserted-by":"crossref","unstructured":"Kaiser J, Gruzelier JH. Timing of puberty and syndromes of schizotypy: a replication. Int J Psychophysiol.\u20081999;34(3):237\u2013247","DOI":"10.1016\/S0167-8760(99)00081-1"},{"key":"2021120820363328700_R52","doi-asserted-by":"crossref","unstructured":"Cohen RZ, Seeman MV, Gotowiec A, Kopala L. Earlier puberty as a predictor of later onset of schizophrenia in women. Am J Psychiatry.\u20081999;156(7):1059\u20131064","DOI":"10.1176\/ajp.156.7.1059"},{"key":"2021120820363328700_R53","doi-asserted-by":"crossref","unstructured":"Ruiz A, Blanco R, Santander J, Miranda E. Relationship between sex differences in onset of schizophrenia and puberty. J Psychiatr Res.\u20082000;34(4\u20135):349\u2013353","DOI":"10.1016\/S0022-3956(00)00030-3"},{"key":"2021120820363328700_R54","doi-asserted-by":"crossref","unstructured":"Frazier JA, Alaghband-Rad J, Jacobsen L, et al. Pubertal development and onset of psychosis in childhood onset schizophrenia. Psychiatry Res.\u20081997;70(1):1\u20137","DOI":"10.1016\/S0165-1781(97)03062-X"},{"key":"2021120820363328700_R55","doi-asserted-by":"crossref","unstructured":"Kaiser J, Gruzelier JH. Timing of puberty and EEG coherence during photic stimulation. Int J Psychophysiol.\u20081996;21(2\u20133):135\u2013149","DOI":"10.1016\/0167-8760(95)00048-8"},{"key":"2021120820363328700_R56","doi-asserted-by":"crossref","unstructured":"Kaiser J, Gruzelier JH. Effects of pubertal timing on EEG coherence and P3 latency. Int J Psychophysiol.\u20081999;34(3):225\u2013236","DOI":"10.1016\/S0167-8760(99)00080-X"},{"key":"2021120820363328700_R57","doi-asserted-by":"crossref","unstructured":"Kaltiala-Heino R, Kosunen E, Rimpela M. Pubertal timing, sexual behavior and self-reported depression in middle adolescence. J Adolesc.\u20082003;26(5):531\u2013545","DOI":"10.1016\/S0140-1971(03)00053-8"},{"key":"2021120820363328700_R58","doi-asserted-by":"crossref","unstructured":"Kaltiala-Heino R, Rimpela M, Rissanen A, Rantanen P. Early puberty and early sexual activity are associated with bulimic-type eating pathology in middle adolescence. J Adolesc Health.\u20082001;28(4):346\u2013352","DOI":"10.1016\/S1054-139X(01)00195-1"},{"key":"2021120820363328700_R59","doi-asserted-by":"crossref","unstructured":"Kaltiala-Heino R, Marttunen M, Rantanen P, Rimpela\u0308 M. Early puberty is associated with mental health problems in middle adolescence. Soc Sci Med.\u20082003;57(6):1055\u20131064","DOI":"10.1016\/S0277-9536(02)00480-X"},{"key":"2021120820363328700_R60","doi-asserted-by":"crossref","unstructured":"Sonis WA, Comite F, Blue J, et al. Behavior problems and social competence in girls with true precocious puberty. J Pediatr.\u20081985;106(1):156\u2013160","DOI":"10.1016\/S0022-3476(85)80489-3"},{"key":"2021120820363328700_R61","unstructured":"Hayward C, Killen JD, Wilson DM, et al. Psychiatric risk associated with early puberty in adolescent girls. J Am Acad Child Adolesc Psychiatry.\u20081997;36(2):255\u2013262"},{"key":"2021120820363328700_R62","doi-asserted-by":"crossref","unstructured":"Aro H, Taipale V. The impact of timing of puberty on psychosomatic symptoms among fourteen- to sixteen-year-old Finnish girls. Child Dev.\u20081987;58(1):261\u2013268","DOI":"10.2307\/1130306"},{"key":"2021120820363328700_R63","doi-asserted-by":"crossref","unstructured":"Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med.\u20081998;28(1):51\u201361","DOI":"10.1017\/S003329179700593X"},{"key":"2021120820363328700_R64","doi-asserted-by":"crossref","unstructured":"Hick KM, Katzman DK. Self-assessment of sexual maturation in adolescent females with anorexia nervosa. J Adolesc Health.\u20081999;24(3):206\u2013211","DOI":"10.1016\/S1054-139X(98)00119-0"},{"key":"2021120820363328700_R65","doi-asserted-by":"crossref","unstructured":"Graber JA, Brooks-Gunn J, Warren MP. The antecedents of menarcheal age: heredity, family environment, and stressful life events. Child Dev.\u20081995;66(2):346\u2013359","DOI":"10.1111\/j.1467-8624.1995.tb00875.x"},{"key":"2021120820363328700_R66","doi-asserted-by":"crossref","unstructured":"Koff E, Rierdan J. Advanced pubertal development and eating disturbance in early adolescent girls. J Adolesc Health.\u20081993;14(6):433\u2013439","DOI":"10.1016\/1054-139X(93)90113-4"},{"key":"2021120820363328700_R67","doi-asserted-by":"crossref","unstructured":"Lintonen T, Rimpela M, Vikat A, Rimpela A. The effect of societal changes on drunkenness trends in early adolescence. Health Educ Res.\u20082000;15(3):261\u2013269","DOI":"10.1093\/her\/15.3.261"},{"key":"2021120820363328700_R68","doi-asserted-by":"crossref","unstructured":"Orr DP, Ingersoll GM. The contribution of level of cognitive complexity and pubertal timing to behavioral risk in young adolescents. Pediatrics.\u20081995;95(4):528\u2013533","DOI":"10.1542\/peds.95.4.528"},{"key":"2021120820363328700_R69","doi-asserted-by":"crossref","unstructured":"Ge X, Conger RD, Elder GH Jr. Coming of age too early: pubertal influences on girls' vulnerability to psychological distress. Child Dev.\u20081996;67(6):386\u2013400","DOI":"10.2307\/1131784"},{"key":"2021120820363328700_R70","doi-asserted-by":"crossref","unstructured":"Brack CJ, Orr DP, Ingersoll G. Pubertal maturation and adolescent self-esteem. J Adolesc Health Care.\u20081988;9(4):280\u2013285","DOI":"10.1016\/0197-0070(88)90250-1"},{"key":"2021120820363328700_R71","doi-asserted-by":"crossref","unstructured":"Wichstr\u00f8m L. Social, psychological and physical correlates of eating problems: a study of the general adolescent population in Norway. Psychol Med.\u20081995;25(3):567\u2013569","DOI":"10.1017\/S0033291700033481"},{"key":"2021120820363328700_R72","doi-asserted-by":"crossref","unstructured":"Tschann JM, Adler NE, Irwin CE Jr, Millstein SG, Turner RA, Kegeles SM. Initiation of substance use in early adolescence: the roles of pubertal timing and emotional distress. Health Psychol.\u20081994;13(4):326\u2013333","DOI":"10.1037\/0278-6133.13.4.326"},{"key":"2021120820363328700_R73","doi-asserted-by":"crossref","unstructured":"Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol.\u20082003;170(1):5\u201311","DOI":"10.1097\/01.ju.0000053866.68623.da"},{"key":"2021120820363328700_R74","unstructured":"Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer in Five Continents. Vol VII. Lyon, France: International Agency for Research on Cancer; 1997. IARC Scientific Publications No. 143"},{"key":"2021120820363328700_R75","doi-asserted-by":"crossref","unstructured":"Zheng T, Holford TR, Ma Z, Ward BA, Flannery J, Boyle P. Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA 1935\u20131992. Int J Cancer.\u20081996;65(6):723\u2013729","DOI":"10.1002\/(SICI)1097-0215(19960315)65:6<723::AID-IJC2>3.0.CO;2-0"},{"key":"2021120820363328700_R76","doi-asserted-by":"crossref","unstructured":"Adami H, Bergstro\u0308m R, Mo\u0308hner M, et al. Testicular cancer in nine Northern European countries. Int J Cancer.\u20081994;59(1):33\u201338","DOI":"10.1002\/ijc.2910590108"},{"key":"2021120820363328700_R77","doi-asserted-by":"crossref","unstructured":"Bergstro\u0308m R, Adami HO, Mo\u0308hner M, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst.\u20081996;88(11):727\u2013733","DOI":"10.1093\/jnci\/88.11.727"},{"key":"2021120820363328700_R78","doi-asserted-by":"crossref","unstructured":"McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol.\u20081999;162(2):361\u2013363","DOI":"10.1016\/S0022-5347(05)68560-6"},{"key":"2021120820363328700_R79","doi-asserted-by":"crossref","unstructured":"Skakkebaek NE, Berthelsen JG, Giwercman A, Mu\u0308ller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl.\u20081987;10(1):19\u201328","DOI":"10.1111\/j.1365-2605.1987.tb00161.x"},{"key":"2021120820363328700_R80","doi-asserted-by":"crossref","unstructured":"Skakkeb\u00e6k NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod Update.\u20082001;16(5):972\u2013978","DOI":"10.1093\/humrep\/16.5.972"},{"key":"2021120820363328700_R81","unstructured":"Skakkeb\u00e6k NE, Rajpert-De Meyts E, Toppari J. Testicular cancer: pathogenesis, diagnosis and endocrine aspects. In: McLachlan R, ed. Endocrinology of Male Reproduction [monograph online]. 2003. Available at: www.endotext.org\/male\/index.htm. Accessed December 13, 2007"},{"key":"2021120820363328700_R82","doi-asserted-by":"crossref","unstructured":"Andersson A-M, Toppari J, Haavisto A-M, et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels exceeds levels in adult men. J Clin Endocrinol Metab.\u20081998;83(2):675\u2013681","DOI":"10.1210\/jc.83.2.675"},{"key":"2021120820363328700_R83","doi-asserted-by":"crossref","unstructured":"Moss AR, Osmond D, Bacchetti P, Torti FM, Gurgin V. Hormonal risk factors in testicular cancer: a case-control study. Am J Epidemiol.\u20081986;124(1):39\u201352","DOI":"10.1093\/oxfordjournals.aje.a114369"},{"key":"2021120820363328700_R84","doi-asserted-by":"crossref","unstructured":"M\u00f8ller H, Skakkeb\u00e6k NE. Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark. Int J Cancer.\u20081996;66(3):287\u2013293","DOI":"10.1002\/(SICI)1097-0215(19960503)66:3<287::AID-IJC2>3.0.CO;2-V"},{"key":"2021120820363328700_R85","doi-asserted-by":"crossref","unstructured":"Swerdlow AJ, Huttly SR, Smith PG. Testis cancer: post-natal hormonal factors, sexual behavior and fertility. Int J Cancer.\u20081989;43(4):549\u2013553","DOI":"10.1002\/ijc.2910430403"},{"key":"2021120820363328700_R86","doi-asserted-by":"crossref","unstructured":"Forman D, Pike MC, Davey G, et al. Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility and exercise. BMJ.\u20081994;308(6941):1393\u20131399","DOI":"10.1136\/bmj.308.6941.1393"},{"key":"2021120820363328700_R87","doi-asserted-by":"crossref","unstructured":"Weir HK, Kreiger N, Marrett L. Age at puberty and risk of testicular germ cell cancer (Ontario, Canada). Cancer Causes Control.\u20081998;9(3):253\u2013258","DOI":"10.1023\/A:1008864902104"},{"key":"2021120820363328700_R88","doi-asserted-by":"crossref","unstructured":"M\u00f8ller H, J\u00f8rgensen N, Forman D. Trends in incidence of testicular cancer in boys and adolescent men. Int J Cancer.\u20081995;61(6):761\u2013764","DOI":"10.1002\/ijc.2910610604"},{"key":"2021120820363328700_R89","doi-asserted-by":"crossref","unstructured":"Wilkinson TJ, Colls BM, Schluter PJ. Increased incidence of germ cell testicular cancer in New Zealand Maoris. Br J Cancer.\u20081992;65(5):769\u2013771","DOI":"10.1038\/bjc.1992.162"},{"key":"2021120820363328700_R90","doi-asserted-by":"crossref","unstructured":"Wilkinson TJ, Colls BM. Testicular cancer and age at puberty. BMJ\u20081994;309(6959):955","DOI":"10.1136\/bmj.309.6959.955"},{"key":"2021120820363328700_R91","doi-asserted-by":"crossref","unstructured":"Henderson BE, Benton B, Jing J, Yu MC, Pike MC. Risk factors for cancer of the testis in young men. Int J Cancer.\u20081979;23(5):598\u2013602","DOI":"10.1002\/ijc.2910230503"},{"key":"2021120820363328700_R92","doi-asserted-by":"crossref","unstructured":"Bernstein L, Pike MC, Depue RH, Ross RK, Moore JW, Henderson BE. Maternal hormone levels in early gestation of cryptorchid males: a case-control study. Br J Cancer.\u20081988;58(3):379\u2013381","DOI":"10.1038\/bjc.1988.223"},{"key":"2021120820363328700_R93","doi-asserted-by":"crossref","unstructured":"Giles GG, Severi G, English DR, et al. Early growth, adult body size and prostate cancer risk. Int J Cancer.\u20082003;103(2):241\u2013245","DOI":"10.1002\/ijc.10810"},{"key":"2021120820363328700_R94","doi-asserted-by":"crossref","unstructured":"Habel LA, Van Den Eeden SK, Friedman GD. Body size at shaving initiation and prostate cancer in large in a large multiracial cohort. Prostate.\u20082000;43(2):136\u2013143","DOI":"10.1002\/(SICI)1097-0045(20000501)43:2<136::AID-PROS8>3.0.CO;2-L"},{"key":"2021120820363328700_R95","doi-asserted-by":"crossref","unstructured":"Hayes RB, de Jong FH, Raatgever J, et al. Physical characteristics and factors related to sexual development and behavior and the risk for prostatic cancer. Eur J Cancer Prev.\u20081992;1(3):239\u2013245","DOI":"10.1097\/00008469-199204000-00005"},{"key":"2021120820363328700_R96","unstructured":"Andersson SO, Baron J, Bergstro\u0308m R, Lindgren C, Wolk A, Adami HO. Life style factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev.\u20081996;5(7):509\u2013513"},{"key":"2021120820363328700_R97","doi-asserted-by":"crossref","unstructured":"Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, Henderson BE. Vasectomy, cigarette smoking and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br J Cancer.\u20081988;57(3):326\u2013331","DOI":"10.1038\/bjc.1988.74"},{"key":"2021120820363328700_R98","unstructured":"Schuman LM, Mandel J, Blackard C, Bauer H, Scarlet J, McHugh R. Epidemiologic study of prostate cancer: preliminary report. Cancer Treat Rep.\u20081977;61(2):181\u2013186"},{"key":"2021120820363328700_R99","doi-asserted-by":"crossref","unstructured":"Kelsey JL, Horn-Ross P. Breast cancer: magnitude of the problem. Epidemiol Rev.\u20081993;15(1):7\u201316","DOI":"10.1093\/oxfordjournals.epirev.a036118"},{"key":"2021120820363328700_R100","unstructured":"Henderson BE, Pike MC, Bernstein L, Ross RK. Breast cancer. In: Schottenfeld D, Fraumeni JR Jr, eds. Cancer, Epidemiology and Prevention. New York, NY: Oxford University Press; 1996:1022\u20131039"},{"key":"2021120820363328700_R101","unstructured":"Russo J, Russo IH. Toward a physiological approach to breast cancer. Cancer Epidemiol Biomarkers Prev.\u20081994;3(4):343\u2013364"},{"key":"2021120820363328700_R102","doi-asserted-by":"crossref","unstructured":"Markey CM, Luque EH, Munoz De Toro M, Sonnenschein C, Soto AM. In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod.\u20082001;65(4):1215\u20131223","DOI":"10.1093\/biolreprod\/65.4.1215"},{"key":"2021120820363328700_R103","doi-asserted-by":"crossref","unstructured":"Fenton SE, Hamm JT, Birnbaum LS, Youngblood GL. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p dioxin (TCDD). Toxicol Sci.\u20082002;67(1):63\u201374","DOI":"10.1093\/toxsci\/67.1.63"},{"key":"2021120820363328700_R104","doi-asserted-by":"crossref","unstructured":"Russo J, Hu YF, Silva ID, Russo IH. Cancer risk related to mammary gland structure and development. Microsc Res Tech.\u20082001;52(2):204\u2013223","DOI":"10.1002\/1097-0029(20010115)52:2<204::AID-JEMT1006>3.0.CO;2-F"},{"key":"2021120820363328700_R105","doi-asserted-by":"crossref","unstructured":"Blanck HM, Marcus M, Tolbert PE, et al. Age at menarche and Tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology.\u20082000;11(6):641\u2013647","DOI":"10.1097\/00001648-200011000-00005"},{"key":"2021120820363328700_R106","doi-asserted-by":"crossref","unstructured":"Vasiliu O, Muttineni J, Karmaus W. In utero exposure to organochlorines and age at menarche. Hum Reprod.\u20082004;19(7):1506\u20131512","DOI":"10.1093\/humrep\/deh292"},{"key":"2021120820363328700_R107","doi-asserted-by":"crossref","unstructured":"Wolff MS, Collman GW, Barrett JC, Huff J. Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol.\u20081996;36:573\u2013596","DOI":"10.1146\/annurev.pa.36.040196.003041"},{"key":"2021120820363328700_R108","doi-asserted-by":"crossref","unstructured":"Bennett LM, Davis BJ. Identification of mammary carcinogens in rodent bioassays. Environ Mol Mutagen.\u20082002;39(2\u20133):150\u2013157","DOI":"10.1002\/em.10068"},{"key":"2021120820363328700_R109","doi-asserted-by":"crossref","unstructured":"Birnbaum, LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect.\u20082003;111(4):389\u2013394","DOI":"10.1289\/ehp.5686"},{"key":"2021120820363328700_R110","doi-asserted-by":"crossref","unstructured":"Lamartiniere CA. Timing of exposure and mammary cancer risk. Mammary Gland Biol Neoplasia.\u20082002;7(1):67\u201376","DOI":"10.1023\/A:1015722507237"},{"key":"2021120820363328700_R111","doi-asserted-by":"crossref","unstructured":"Tokunaga M, Land CE, Yamamoto T, et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950\u20131985. Radiat Res.\u20081987;112(2):243\u2013272","DOI":"10.2307\/3577254"},{"key":"2021120820363328700_R112","doi-asserted-by":"crossref","unstructured":"Dearry AD, Collman GW, Saint C, Fields N, Redd S. Building a network of research in children's environmental health. Environ Health Perspect.\u20081999;107(suppl 3):391","DOI":"10.1289\/ehp.99107s3391"},{"key":"2021120820363328700_R113","doi-asserted-by":"crossref","unstructured":"Biro FM, Lucky AW, Simbartl LA, et al. Pubertal maturation in girls and the relationship to anthropometric changes: pathways to puberty. J Pediatr.\u20082003;142(6):643\u2013646","DOI":"10.1067\/mpd.2003.244"},{"key":"2021120820363328700_R114","unstructured":"US Environmental Protection Agency. Guidelines for Developmental Toxicity Risk Assessment. Washington, DC: Risk Assessment Forum, US Environmental Protection Agency; 1991. Report EPA\/600\/FR-91\/001. Federal Register No. 56 (234) 63798\u201363826. Available at: www.epa.gov\/ncea\/raf\/pdfs\/devtox.pdf. Accessed December 13, 2007"},{"key":"2021120820363328700_R115","doi-asserted-by":"crossref","unstructured":"Kimmel CA, Makris SL. Recent developments in regulatory requirements for developmental toxicology. Toxicol Lett.\u20082001;120(1\u20133):73\u201382","DOI":"10.1016\/S0378-4274(01)00309-5"},{"key":"2021120820363328700_R116","unstructured":"US Environmental Protection Agency. OPPTS Harmonized Test Guidelines. Series 870 Health Effects Test Guidelines. Washington, DC: Office of Prevention, Pesticides and Toxic Substances, US Environmental Protection Agency; 1998. Available at: www.epa.gov\/*oppts*frs\/publications\/*OPPTS*_*Harmonized*\/*870*_Health_Effects_*Test*_*Guidelines*\/index.html. Accessed December 13, 2007"},{"key":"2021120820363328700_R117","unstructured":"US Environmental Protection Agency. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report. Washington, DC: Office of Prevention, Pesticides and Toxic Substances, US Environmental Protection Agency; 1998. Available at: www.epa.gov\/endo\/pubs\/edspoverview\/*final*rpt.htm. Accessed December 13, 2007"},{"key":"2021120820363328700_R118","doi-asserted-by":"crossref","unstructured":"Goldman JM, Laws SC, Balchak SK, Cooper RL, Kavlock RJ. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid activity in the female rat\u2014a focus on the EDSTAC recommendations. Crit Rev Toxicol.\u20082000;30(2):135\u2013196","DOI":"10.1080\/10408440091159185"},{"key":"2021120820363328700_R119","doi-asserted-by":"crossref","unstructured":"Gray LE Jr, Ostby J, Ferrell J, et al. A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. Fundam Appl Toxicol.\u20081989;12(1):92\u2013108","DOI":"10.1093\/toxsci\/12.1.92"},{"key":"2021120820363328700_R120","doi-asserted-by":"crossref","unstructured":"Gray LE Jr, Ostby J, Sigmonn R, et al. The development of a protocol to assess reproductive effects of toxicants in the rat. Reprod Toxicol.\u20081988;2(3\u20134):281\u2013287","DOI":"10.1016\/0890-6238(88)90032-9"},{"key":"2021120820363328700_R121","doi-asserted-by":"crossref","unstructured":"Laws SC, Ferrell JM, Stoker TE, Schmid J, Cooper RL. The effects of atrazine on female Wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol Sci.\u20082000;58(2):366\u2013376","DOI":"10.1093\/toxsci\/58.2.366"},{"key":"2021120820363328700_R122","doi-asserted-by":"crossref","unstructured":"Marty MS, Crissman JW, Carney EW. Evaluation of the EDSTAC female pubertal assay in CD rats using 17beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. Toxicol Sci.\u20081999;52(2):269\u2013277","DOI":"10.1093\/toxsci\/52.2.269"},{"key":"2021120820363328700_R123","doi-asserted-by":"crossref","unstructured":"Ashby J, Lefevre PA. The weanling male rat as an assay for endocrine disruption: preliminary observations. Regul Toxicol Pharmacol.\u20081997;26(3):330\u2013337","DOI":"10.1006\/rtph.1997.1177"},{"key":"2021120820363328700_R124","doi-asserted-by":"crossref","unstructured":"Gray LE Jr, Kelce WR, Wiese T, et al. Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanisms. Reprod Toxicol.\u20081997;11(5):719\u2013750","DOI":"10.1016\/S0890-6238(97)00025-7"},{"key":"2021120820363328700_R125","doi-asserted-by":"crossref","unstructured":"Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol.\u20081994;126(2):276\u2013285","DOI":"10.1006\/taap.1994.1117"},{"key":"2021120820363328700_R126","doi-asserted-by":"crossref","unstructured":"Marty MS, Crissman JW, Carney EW. Evaluation of the male pubertal assay's ability to detect thyroid inhibitors and dopaminergic agents. Toxicol Sci.\u20082001;60(1):63\u201376","DOI":"10.1093\/toxsci\/60.1.63"},{"key":"2021120820363328700_R127","doi-asserted-by":"crossref","unstructured":"Monosson E, Kelce WR, Lambright C, Ostby J, Gray LE Jr. Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol Ind Health.\u20081999;15(1\u20132):65\u201379","DOI":"10.1177\/074823379901500107"},{"key":"2021120820363328700_R128","doi-asserted-by":"crossref","unstructured":"Stoker TE, Laws SC, Guidici DL, Cooper RL. The effect of atrazine on puberty in male Wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function. Toxicol Sci.\u20082000;58(1):50\u201359","DOI":"10.1093\/toxsci\/58.1.50"},{"key":"2021120820363328700_R129","doi-asserted-by":"crossref","unstructured":"Stoker TE, Parks LG, Gray LE, Cooper RL. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat\u2014a focus on the EDSTAC recommendations. Endocrine Screening and Testing Advisory Committee. Crit Rev Toxicol.\u20082000;30(2):197\u2013252","DOI":"10.1080\/10408440091159194"},{"key":"2021120820363328700_R130","doi-asserted-by":"crossref","unstructured":"Kelce WR, Wilson EM. Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications. J Mol Med.\u20081997;75(3):198\u2013207","DOI":"10.1007\/s001090050104"},{"key":"2021120820363328700_R131","unstructured":"International Programme on Chemical Safety (IPCS). Environmental Health Criteria 225: Principles for Evaluating Health Risks to Reproduction Associated with Exposure to Chemicals. Geneva, Switzerland: World Health Organization; 2001"},{"key":"2021120820363328700_R132","unstructured":"Integrated Risk Information System [database online]. Washington, DC: National Center for Environmental Assessment, US Environmental Protection Agency; 2004. Available at: http:\/\/cfpub.epa.gov\/ncea\/iris\/index.cfm. Accessed December 13, 2007"},{"key":"2021120820363328700_R133","unstructured":"Faustman EM, Ponce RA, Seeley MR, Whittaker SG. Experimental approaches to evaluate mechanisms of developmental toxicity. In: Hood RD, ed. Handbook of Developmental Toxicology. Boca Raton, FL: CRC Press; 1996:13\u201341"},{"key":"2021120820363328700_R134","unstructured":"US Environmental Protection Agency. Guidelines for Reproductive Toxicity Risk Assessment. Washington, DC: Risk Assessment Forum, US Environmental Protection Agency; 1996. Federal Register No. 61 (212) 56274-26322, 31. Report No. 630\/R-96\/009. Available at: http:\/\/cfpub.epa.gov\/ncea\/raf\/pdfs\/repro51.pdf. Accessed December 13, 2007"},{"key":"2021120820363328700_R135","unstructured":"Daston G, Kimmel C, eds. An Evaluation and Interpretation of Reproductive Endpoints for Human Health Risk Assessment. Washington, DC: ILSI Press; 1999"},{"key":"2021120820363328700_R136","doi-asserted-by":"crossref","unstructured":"Kimmel CA, Grant LD, Sloan CS, Gladen BC. Chronic low-level lead toxicity in the rat: I\u2014maternal toxicity and perinatal effects. Toxicol Appl Pharmacol.\u20081980;56(1):28\u201341","DOI":"10.1016\/0041-008X(80)90129-5"},{"key":"2021120820363328700_R137","doi-asserted-by":"crossref","unstructured":"Grant LD, Kimmel CA, West GL, Martinez-Vargas CM, Howard JL. Chronic low-level lead toxicity in the rat: II\u2014effects on postnatal physical and behavioral development. Toxicol Appl Pharmacol.\u20081980;56(1):42\u201358","DOI":"10.1016\/0041-008X(80)90130-1"},{"key":"2021120820363328700_R138","doi-asserted-by":"crossref","unstructured":"Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens A, Bethel J. Blood lead concentration and delayed puberty in girls. N Engl J Med.\u20082003;348(16):1527\u20131536","DOI":"10.1056\/NEJMoa020880"},{"key":"2021120820363328700_R139","doi-asserted-by":"crossref","unstructured":"Wu T, Buck GM, Mendola P. Blood lead levels and sexual maturation in U.S. girls: the Third National Health and Nutrition Examination Survey, 1988\u20131994. Environ Health Perspect.\u20082003;111(5):737\u2013741","DOI":"10.1289\/ehp.6008"},{"key":"2021120820363328700_R140","doi-asserted-by":"crossref","unstructured":"Harris SJ, Cecil HC, Bitman J. Embryotoxic effects of polybrominated biphenyls (PBB) in rats. Environ Health Perspect.\u20081978;23:295\u2013300","DOI":"10.1289\/ehp.7823295"},{"key":"2021120820363328700_R141","doi-asserted-by":"crossref","unstructured":"Henck JW, Mattson JL, Rezabek DH, Carlson CL, Rech RH. Developmental neurotoxicity of polybrominated biphenyls. Neurotoxicol Teratol.\u20081994;16(4):391\u2013399","DOI":"10.1016\/0892-0362(94)90028-0"},{"key":"2021120820363328700_R142","doi-asserted-by":"crossref","unstructured":"McCormack KM, Lepper LF, Wilson DM, Hook JB. Biochemical and physiological sequelae to perinatal exposure to polybrominated biphenyls: a multigeneration study in rats. Toxicol Appl Pharmacol.\u20081981;59(2):300\u2013313","DOI":"10.1016\/0041-008X(81)90202-7"},{"key":"2021120820363328700_R143","unstructured":"US Environmental Protection Agency. Guidelines for carcinogen risk assessment and supplemental guidance for assessing susceptibility from early-life exposure to carcinogens. Fed Reg.\u20082005;70(66):17765\u201317817"},{"key":"2021120820363328700_R144","doi-asserted-by":"crossref","unstructured":"Williams JM, Dunlop LC. Pubertal timing and self-reported delinquency among male adolescents. J Adolesc.\u20081999;22(1):157\u2013171","DOI":"10.1006\/jado.1998.0208"},{"key":"#cr-split#-2021120820363328700_R145.1","unstructured":"1998 May. Report No. 630\/R-95\/001F. Federal Register No. 63(93) 26926-26954. Available at: http:\/\/cfpub.epa.gov\/ncea\/cfm\/recordisplay.cfm?deid=12479. Accessed December 13, 2007"},{"key":"#cr-split#-2021120820363328700_R145.2","unstructured":"U.S. Environmental Protection Agency. Guidelines for Neurotoxicity Risk Assessment. Washington, DC: Risk Assessment Forum, US Environmental Protection Agency; 1998 May. Report No. 630\/R-95\/001F. Federal Register No. 63"},{"key":"#cr-split#-2021120820363328700_R145.3","unstructured":"(93) 26926-26954. Available at: http:\/\/cfpub.epa.gov\/ncea\/cfm\/recordisplay.cfm?deid=12479. Accessed December 13, 2007"},{"key":"2021120820363328700_R146","unstructured":"Rajpert-De Meyts E, Skakkebaek NE. The role of puberty for testicular cancer. In: Bourguignon JP, Plant TM, eds. The Onset of Puberty in Perspective. Amsterdam, Netherlands: Elsevier Science; 2000:201\u2013213"},{"key":"2021120820363328700_R147","doi-asserted-by":"crossref","unstructured":"Gray LE Jr, Foster PMD. Significance of experimental studies for assessing adverse effects of endocrine-disrupting chemicals. Pure Appl Chem.\u20082003;75(11):2125\u20132141","DOI":"10.1351\/pac200375112125"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/Supplement_3\/S218\/890455\/zpe6020800s218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/121\/Supplement_3\/S218\/890455\/zpe6020800s218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:31:36Z","timestamp":1684218696000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/121\/Supplement_3\/S218\/29260\/Public-Health-Implications-of-Altered-Puberty"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,1]]},"references-count":149,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2008,2,1]]},"published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-1813g","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,1]]}}}